HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
Position
Managing Director
Company
HaemaLogiX
SydneyManufacturingBiotechnologyHealth CareTherapeuticsDescription
HaemaLogiX Ltd, a clinical stage Australian biotech, is pleased to announce the appointment of Damian Clarke-Bruce as Managing Director and CEO, effective 13 November 2023.
Quick answer
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO (November 14, 2023). HaemaLogiX is based in Sydney, New South Wales, Australia.
- Who is the new Managing Director at HaemaLogiX?
- HaemaLogiX named Damian Clarke-Bruce Managing Director, announced November 14, 2023.
- What did HaemaLogiX announce on November 14, 2023?
- HaemaLogiX Ltd, a clinical stage Australian biotech, is pleased to announce the appointment of Damian Clarke-Bruce as Managing Director and CEO, effective 13 November 2023.
- What does HaemaLogiX do?
- HaemaLogiX focus is the development and commercialisation of novel immuno-oncology and immune-therapies.
- Where is HaemaLogiX based?
- HaemaLogiX is based in Sydney, New South Wales, Australia.
- Which similar companies made leadership changes around the same time?
- Century Therapeutics (November 9, 2023), Genentech (November 7, 2023), Intensity Therapeutics (December 12, 2023) and Rev.1 Engineering (November 13, 2023) also announced leadership changes within 45 days of HaemaLogiX.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer (November 9, 2023)
- Departure of Alexander Hardy & Appointment of Interim Chief Exec Officer at Genentech (November 7, 2023)
- Intensity Therapeutics Appoints Joseph Talamo, CPA, as Chief Financial Officer (December 12, 2023)
- Rev.1 Engineering Appoints New CEO, COO, and CTO (November 13, 2023)
- Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO (November 13, 2023)
- Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer (November 13, 2023)
Who to call at HaemaLogiX, and when
A new leader at HaemaLogiX brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day HaemaLogiX raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HaemaLogiX, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HaemaLogiX. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HaemaLogiX changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
HaemaLogiX changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.